OCDX News and Press, Ortho Clinical Diagnostics plc

One of the largest tech deals in M&A history was announced last week. Chipmaker Broadcom entered into an agreement to acquire VMware for $69 billion in a cash or stock deal. Broadcom's acquisition of VMware will be reviewed by either the FTC or the DOJ, the Committee on Foreig...

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc (“Ortho”), one of the world’s larger pure-p...

Potential deal in the works, ManTech International Corporation entered into a definitive agreement to be acquired by global investment firm Carlyle. Diamondback to acquire all of the publicly held common units representing the limited partner interests in Rattler not already owned by ...

RARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho” or the “Company”), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that based on a preliminary vote c...

The following slide deck was published by Ortho Clinical Diagnostics Holdings plc in conjunction with their 2022 Q1 earnings call. For further details see: Ortho Clinical Diagnostics Holdings plc 2022 Q1 - Results - Earnings Call Presentation

Image source: The Motley Fool. Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) Q1 2022 Earnings Call May 04, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Ortho Clinical Diagnostics Holdings plc (OCDX) Q1 2...

Ortho Clinical Diagnostics press release (NASDAQ:OCDX): Q1 Non-GAAP EPS of $0.23 beats by $0.03. Revenue of $495M (-0.9% Y/Y) misses by $12.41M. Shares -2.27%. For further details see: Ortho Clinical Diagnostics Non-GAAP EPS of $0.23 beats by $0.03, revenue of $495M misses by $12.41M

RARITAN, N.J., May 04, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company” or “Ortho Clinical Diagnostics”), one of the world’s largest pure-play in-vitro diagnostics (IVD) companies, today announced financi...

RARITAN, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies, has been recognized with a prestigious Gold 2022 Edison Award for its VITROS ® Anti-SARS-CoV-2 ...

RARITAN, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it will report results for its first quarter 2022 ended April 3, 2022, after the market close...